Anna Stelling, PhD – www.brainwork.md

30th October 2020

The risk of a clinical event in radiologically isolated syndrome

https://www.brainwork.md/content/uploads/2020/10/Brainwork_clinical_event_radiologically_isolated_syndrome-scaled.jpg 2560 1707 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 30th October 2020 6th November 2020

Radiologically isolated syndrome (RIS) is a clinical finding that describes individuals with magnetic resonance imaging (MRI) patterns similar to those seen in multiple sclerosis patients. However, affected patients do not…

Anna Stelling, PhD
0
0

14th October 2020

Deep brain stimulation against chronic cluster headaches: Yes or no?

https://www.brainwork.md/content/uploads/2020/10/Brainwork_deep_brain_stimulation_against_chronic_cluster_headaches-scaled.jpg 2560 1920 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 14th October 2020 16th October 2020

Cluster headaches, a disease belonging to the class of trigeminal autonomic cephalgias, are seen chronically in about 15% of all cluster headache patients.1,2 Affected individuals have always been treated with…

Anna Stelling, PhD
0
0

7th October 2020

Speaking to Prof. Andrea Rossetti – “Often in life, things happen by chance, but then you have to seize the chance“

https://www.brainwork.md/content/uploads/2020/10/Brainwork-Andrea-Rossetti-scaled.jpg 2560 1600 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 7th October 2020 7th October 2020

Prof. Andrea Rossetti is the head of the Electroencephalography (EEG) and Epilepsy unit of the Neurological department of the University Hospital of Lausanne in Switzerland. He recently published a potentially…

Anna Stelling, PhD
0
0

26th September 2020

New data on endovascular treatment in patients with cerebral venous thrombosis

https://www.brainwork.md/content/uploads/2020/09/Brainwork_New-data-endovascular-treatment-in-patients-with-cerebral-venous-thrombosis-scaled.jpg 2560 1707 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 26th September 2020 8th October 2020

Stroke can have several causes, and one of them is cerebral venous thrombosis (CVT), affecting mostly young adult and middle-aged patients.1 The current standard for CVT is anticoagulation treatment with…

Anna Stelling, PhD
0
0

25th September 2020

Deep brain stimulation in Parkinson’s disease – five-year outcomes

https://www.brainwork.md/content/uploads/2020/09/Brainwork-New-data-on-endovascular-treatment-in-patients-with-cerebral-venous-thrombosis-scaled.jpg 2560 1707 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 25th September 2020 8th October 2020

It has been consistently shown that deep brain stimulation (DBS) in combination with medication is superior to medication alone in mid- and advanced-stage Parkinson’s disease (PD).1 These findings also motivated…

Anna Stelling, PhD
0
0

18th September 2020

Ageing in multiple sclerosis – what do we know?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-Ageing-in-multiple-sclerosis-–-what-do-we-know.png 2846 1601 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 18th September 2020 23rd September 2020

“Ageing comes with many issues in multiple sclerosis (MS): progression, comorbidities, cognition problems and response to treatment”, Pierre Duquette (Department of Neuroscience, University of Montreal, Canada), the chair of the…

Anna Stelling, PhD
0
0

17th September 2020

Is disease-modifying treatment in primary progressive multiple sclerosis effective after all?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Is-disease-modifying-treatment-primary-progressive-multiplesclerosis-effective-after-all-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

Until now, several randomised controlled trials and real-world studies could not show the clinical benefit of disease‑modifying treatments (DMTs) in primary progressive multiple sclerosis (PPMS).1-4 However, some recently published results…

Anna Stelling, PhD
0
0

17th September 2020

Neurofilament light chain levels as a biomarker in multiple sclerosis

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Neurofilament-light-chain-levels-as-a-biomarker-in-multiple-sclerosis-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

It has been previously shown that the neuronal cytoskeletal protein neurofilament light chain (NfL) is released into the blood and cerebrospinal fluid (CSF) upon neuroaxonal injury.1 Hence it was not…

Anna Stelling, PhD
0
0

31st August 2020

A reliable blood test for Alzheimer’s disease – is it becoming a reality?

https://www.brainwork.md/content/uploads/2020/08/Brainwork-Alzheimers-Dementia-Biomarkers-1024x683.jpg 1024 683 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 31st August 2020 31st August 2020

The increasing number of patients suffering from dementia caused by Alzheimer’s disease (AD) is a significant challenge for society and requires action by healthcare professionals and researchers worldwide. One important…

Anna Stelling, PhD
0
0

25th August 2020

Speaking to Prof. Günther Deuschl – “The world is not a world of competitors, it is a world of collaborators.“

https://www.brainwork.md/content/uploads/2020/08/Deuschl-20201-.jpg 1041 1092 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 25th August 2020 25th August 2020

Even now, after having retired, Prof. Günther Deuschl’s ultimate goal is to cure patients. As an expert in movement disorders, he has contributed to this field substantially during his career.…

Anna Stelling, PhD
0
0